Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
75.36
+1.32 (1.78%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Ionis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
12,44912,8145,5207,2585,3654,297
Upgrade
Market Cap Growth
139.56%132.13%-23.95%35.28%24.86%-45.65%
Upgrade
Enterprise Value
12,38412,6195,0246,9914,6313,606
Upgrade
Last Close Price
75.3679.1134.9650.5937.7730.43
Upgrade
PS Ratio
13.1913.587.839.229.135.30
Upgrade
PB Ratio
25.1626.209.3818.779.375.57
Upgrade
P/TBV Ratio
25.4526.209.3818.779.375.57
Upgrade
P/FCF Ratio
-----228.03
Upgrade
P/OCF Ratio
-----139.52
Upgrade
EV/Sales Ratio
13.1213.377.138.887.884.45
Upgrade
EV/FCF Ratio
-----191.38
Upgrade
Debt / Equity Ratio
5.355.353.335.092.391.62
Upgrade
Debt / FCF Ratio
-----66.39
Upgrade
Net Debt / Equity Ratio
-0.13-0.13-0.58-0.96-1.10-1.14
Upgrade
Net Debt / EBITDA Ratio
0.180.180.741.091.6071.44
Upgrade
Net Debt / FCF Ratio
0.200.200.631.122.17-46.81
Upgrade
Asset Turnover
0.290.290.240.280.230.32
Upgrade
Inventory Turnover
82.5882.5891.4961.6736.1827.98
Upgrade
Quick Ratio
3.513.517.745.446.499.13
Upgrade
Current Ratio
3.833.838.475.907.079.75
Upgrade
Return on Equity (ROE)
-70.80%-70.80%-93.10%-76.34%-40.12%-3.77%
Upgrade
Return on Assets (ROA)
-7.31%-7.31%-9.91%-8.00%-9.96%-0.75%
Upgrade
Return on Invested Capital (ROIC)
-90.05%-114.15%-364.50%---
Upgrade
Return on Capital Employed (ROCE)
-13.90%-13.90%-17.60%-13.90%-18.50%-1.30%
Upgrade
Earnings Yield
-3.06%-2.98%-8.22%-5.05%-5.03%-0.67%
Upgrade
FCF Yield
-2.57%-2.50%-9.89%-4.57%-5.41%0.44%
Upgrade
Buyback Yield / Dilution
-7.02%-7.02%-4.42%-0.95%-0.59%-1.01%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.